131 related articles for article (PubMed ID: 28518060)
1. Analysis of healthy and tumour DNA methylation distributions in kidney-renal-clear-cell-carcinoma using Kullback-Leibler and Jensen-Shannon distance measures.
Ramakrishnan N; Bose R
IET Syst Biol; 2017 Jun; 11(3):99-104. PubMed ID: 28518060
[TBL] [Abstract][Full Text] [Related]
2. Accounting for differential variability in detecting differentially methylated regions.
Wang Y; Teschendorff AE; Widschwendter M; Wang S
Brief Bioinform; 2019 Jan; 20(1):47-57. PubMed ID: 29912290
[TBL] [Abstract][Full Text] [Related]
3. PON1 hypermethylation is associated with progression of renal cell carcinoma.
Li X; Yu Q
J Cell Mol Med; 2019 Oct; 23(10):6646-6657. PubMed ID: 31400051
[TBL] [Abstract][Full Text] [Related]
4. Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival.
Hu CY; Mohtat D; Yu Y; Ko YA; Shenoy N; Bhattacharya S; Izquierdo MC; Park AS; Giricz O; Vallumsetla N; Gundabolu K; Ware K; Bhagat TD; Suzuki M; Pullman J; Liu XS; Greally JM; Susztak K; Verma A
Clin Cancer Res; 2014 Aug; 20(16):4349-60. PubMed ID: 24916699
[TBL] [Abstract][Full Text] [Related]
5. Reproducibility-optimized detection of differential DNA methylation.
Suni V; Seyednasrollah F; Ghimire B; Junttila S; Laiho A; Elo LL
Epigenomics; 2020 May; 12(9):747-755. PubMed ID: 32496849
[No Abstract] [Full Text] [Related]
6. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
7. On the Jensen-Shannon Symmetrization of Distances Relying on Abstract Means.
Nielsen F
Entropy (Basel); 2019 May; 21(5):. PubMed ID: 33267199
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC).
Evelönn EA; Degerman S; Köhn L; Landfors M; Ljungberg B; Roos G
Tumour Biol; 2016 Aug; 37(8):10219-28. PubMed ID: 26831665
[TBL] [Abstract][Full Text] [Related]
9. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
10. Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma.
Chen G; Wang Y; Wang L; Xu W
Oncotarget; 2017 Jan; 8(3):5268-5280. PubMed ID: 28029655
[TBL] [Abstract][Full Text] [Related]
11. DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.
Malouf GG; Su X; Zhang J; Creighton CJ; Ho TH; Lu Y; Raynal NJ; Karam JA; Tamboli P; Allanick F; Mouawad R; Spano JP; Khayat D; Wood CG; Jelinek J; Tannir NM
Clin Cancer Res; 2016 Dec; 22(24):6236-6246. PubMed ID: 27256309
[TBL] [Abstract][Full Text] [Related]
12. Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma.
Morris MR; Gentle D; Abdulrahman M; Clarke N; Brown M; Kishida T; Yao M; Teh BT; Latif F; Maher ER
Br J Cancer; 2008 Jan; 98(2):496-501. PubMed ID: 18195710
[TBL] [Abstract][Full Text] [Related]
13. Analysis of distribution of DNA methylation in kidney-renal-clear-cell-carcinoma specific genes using entropy.
Ramakrishnan N; Bose R
Genom Data; 2016 Dec; 10():109-113. PubMed ID: 27818943
[TBL] [Abstract][Full Text] [Related]
14. Ranking genomic features using an information-theoretic measure of epigenetic discordance.
Jenkinson G; Abante J; Koldobskiy MA; Feinberg AP; Goutsias J
BMC Bioinformatics; 2019 Apr; 20(1):175. PubMed ID: 30961526
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation profiling distinguishes histological subtypes of renal cell carcinoma.
Slater AA; Alokail M; Gentle D; Yao M; Kovacs G; Maher ER; Latif F
Epigenetics; 2013 Mar; 8(3):252-67. PubMed ID: 23428843
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of HOXA5 and MSH2 gene in clear cell renal cell carcinoma.
Yoo KH; Park YK; Kim HS; Jung WW; Chang SG
Pathol Int; 2010 Oct; 60(10):661-6. PubMed ID: 20846263
[TBL] [Abstract][Full Text] [Related]
17. [The hyper-methylated genes microRNA as potential markers of clear-cell carcinoma of kidney].
Beresneva EV; Loginov VI; Khodyrev DS; Pronina IV; Kazubskaya TP; Karpukhin AV; Braga EA; Kushlinskii NE
Klin Lab Diagn; 2017 Jan; 62(1):13-8. PubMed ID: 30615358
[TBL] [Abstract][Full Text] [Related]
18. CpG dinucleotide-specific hypermethylation of the TNS3 gene promoter in human renal cell carcinoma.
Carter JA; Górecki DC; Mein CA; Ljungberg B; Hafizi S
Epigenetics; 2013 Jul; 8(7):739-47. PubMed ID: 23803643
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
20. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]